Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of TUBG1 monoclonal antibody, clone TU-32
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | WB,ICC |
More info about TUBG1 monoclonal antibody, clone TU-32
| Brand: | Abnova |
| Reference: | MAB3661 |
| Product name: | TUBG1 monoclonal antibody, clone TU-32 |
| Product description: | Mouse monoclonal antibody raised against synthetic peptide of TUBG1. |
| Clone: | TU-32 |
| Isotype: | IgG1 |
| Gene id: | 7283 |
| Gene name: | TUBG1 |
| Gene alias: | TUBG|TUBGCP1 |
| Gene description: | tubulin, gamma 1 |
| Immunogen: | A synthetic peptide corresponding to amino acids 434-449 of human TUBG1. |
| Immunogen sequence/protein sequence: | EYHAATRPDYISWGTQ |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody recognizes an epitope (amino acids 434-449 in human) within C-terminus of TUBG1, a 48 KDa structural constituent of cytoskeleton and microtubule organizing center (MTOC). |
| Reactivity: | Human |
| Applications: | WB,ICC |
| Shipping condition: | Blue Ice |
| Publications: | Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action.Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, Hebert TE. Mol Pharmacol. 2001 Jan;59(1):144-52. |